|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 07/15/07 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
| 29/15/29 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| +0.56% | -5.82% | -6.74% | +8.95% | -0.67% | -2.45% | +9.99% | -29.88% | +195.30% | 4.55TCr | |
| +0.66% | -1.07% | +0.69% | +28.15% | +157.51% | +343.96% | +530.14% | +594.11% | - | 4.37TCr | |
| +1.49% | +2.49% | +12.26% | +48.93% | +17.86% | +42.86% | +24.75% | +3.15% | +241.04% | 4.31TCr | |
| +2.11% | +0.67% | +1.83% | +31.93% | +16.46% | +6.49% | +78.25% | -4.08% | +953.69% | 3.94TCr | |
| +0.34% | -4.94% | -11.49% | +3.35% | +3.72% | +9.34% | +40.23% | -16.99% | +135.16% | 3.19TCr | |
| +0.53% | -1.91% | +6.61% | +18.64% | - | - | - | - | - | 1.73TCr | |
| +1.34% | +0.76% | +2.92% | +27.36% | +6.01% | +19.94% | +112.62% | +228.83% | +1,875.48% | 1.64TCr | |
| +2.07% | -0.77% | +2.94% | +12.61% | +15.64% | +13.07% | +32.89% | -40.67% | +92.84% | 1.42TCr | |
| -1.85% | -2.72% | -2.48% | +44.91% | +36.91% | +79.39% | +31.45% | -37.39% | +239.01% | 1.33TCr | |
| -0.22% | +6.69% | +3.54% | +14.36% | -7.29% | -0.90% | -35.47% | -36.33% | +121.32% | 1.31TCr | |
| +0.21% | -0.06% | -0.18% | +28.66% | +22.89% | +40.00% | -2.39% | -43.31% | +170.14% | 1.13TCr | |
| +5.42% | -3.24% | +19.40% | +18.90% | +5.35% | -26.92% | - | - | - | 1.06TCr | |
| -1.63% | +2.10% | -6.52% | +17.17% | -17.23% | +40.95% | +506.14% | +207.09% | +2,448.59% | 1.02TCr | |
| +5.88% | +3.54% | -14.36% | +90.57% | +50.02% | +26.37% | +56.74% | -50.15% | - | 1.01TCr | |
| -0.27% | +1.26% | -4.72% | +31.41% | +69.20% | +153.13% | +721.00% | +227.96% | +1,028.09% | 958.85Cr | |
| -0.29% | -1.58% | -2.35% | +33.93% | +47.32% | +142.45% | +491.49% | +81.46% | - | 955.9Cr | |
| -1.20% | -6.22% | -9.89% | +24.95% | +12.15% | +717.18% | +1,582.19% | +8.61% | - | 934.15Cr | |
| +5.07% | +8.07% | +30.87% | +161.14% | +173.75% | +95.63% | +79.32% | +5.10% | +1,346.81% | 902.31Cr | |
| -5.11% | -9.29% | -10.13% | -30.45% | -34.98% | -15.81% | +17.87% | +42.06% | +68.88% | 900.89Cr | |
| Average | +0.72% | -2.04% | +0.64% | +32.39% | +31.92% | +93.59% | +251.60% | +67.03% | +685.87% | 1.83TCr | |
| Weighted average by Cap. | +0.90% | -2.65% | +0.53% | +28.64% | +35.01% | +85.78% | +189.86% | +90.98% | +554.96% |
- Stock Market
- Stocks
- Stock
- Sector Pharmacyclics, Inc.
Select your edition
All financial news and data tailored to specific country editions
